Evolucumab (Repatha) and alirocumab (Praluent) are injectable monoclonal antibodies. They have been joined by inclisiran ...

Novartis' cholesterol-lowering drug Leqvio will be made available on the ... aimed at improving the manufacturing of oligonucleotide drugs in the UK. Professor Kausik Ray of Imperial College ...

Novartis upped the ante with Leqvio (inclisiran), an RNA interference ... as it can be dosed alongside current cholesterol drugs like statins. Early trials suggest it as efficacy that matches ...

These drugs reduce the cholesterol your body makes and help ... alirocumab (Praluent), evolocumab (Repatha), and inclisiran (Leqvio)-- are injections that keep LDL receptors free to bind to ...